- ¥2bn
- ¥2bn
- ¥2bn
- 46
- 25
- 61
- 38
Annual balance sheet for PhoenixBio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,328 | 1,326 | 1,555 | 1,385 | 1,150 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 160 | 226 | 287 | 217 | 170 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,799 | 1,854 | 2,292 | 2,132 | 1,717 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 702 | 410 | 539 | 543 | 528 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,516 | 2,280 | 3,019 | 2,715 | 2,285 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 399 | 439 | 1,286 | 421 | 567 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,422 | 1,452 | 1,504 | 918 | 920 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,094 | 828 | 1,514 | 1,798 | 1,365 |
| Total Liabilities & Shareholders' Equity | 2,516 | 2,280 | 3,019 | 2,715 | 2,285 |
| Total Common Shares Outstanding |